These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18711142)

  • 1. Supralinear potentiation of NR1/NR3A excitatory glycine receptors by Zn2+ and NR1 antagonist.
    Madry C; Betz H; Geiger JR; Laube B
    Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12563-8. PubMed ID: 18711142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of Glycine-Gated NR1/NR3A NMDA Receptors Relieves Ca-Dependent Outward Rectification.
    Madry C; Betz H; Geiger JR; Laube B
    Front Mol Neurosci; 2010; 3():6. PubMed ID: 20407581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits.
    Chatterton JE; Awobuluyi M; Premkumar LS; Takahashi H; Talantova M; Shin Y; Cui J; Tu S; Sevarino KA; Nakanishi N; Tong G; Lipton SA; Zhang D
    Nature; 2002 Feb; 415(6873):793-8. PubMed ID: 11823786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits.
    Smothers CT; Woodward JJ
    J Pharmacol Exp Ther; 2007 Aug; 322(2):739-48. PubMed ID: 17502428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function.
    Madry C; Mesic I; Bartholomäus I; Nicke A; Betz H; Laube B
    Biochem Biophys Res Commun; 2007 Mar; 354(1):102-8. PubMed ID: 17214961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of glycine-activated diheteromeric NR1/NR3 receptors in human embryonic kidney 293 cells Is NR1 splice variant-dependent.
    Smothers CT; Woodward JJ
    J Pharmacol Exp Ther; 2009 Dec; 331(3):975-84. PubMed ID: 19726695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A.
    Yao Y; Mayer ML
    J Neurosci; 2006 Apr; 26(17):4559-66. PubMed ID: 16641235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of NR1/NR2 and NR1/NR3 heterodimers constitutes the initial step in N-methyl-D-aspartate receptor assembly.
    Schüler T; Mesic I; Madry C; Bartholomäus I; Laube B
    J Biol Chem; 2008 Jan; 283(1):37-46. PubMed ID: 17959602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSD-95 eliminates Src-induced potentiation of NR1/NR2A-subtype NMDA receptor channels and reduces high-affinity zinc inhibition.
    Yamada Y; Iwamoto T; Watanabe Y; Sobue K; Inui M
    J Neurochem; 2002 May; 81(4):758-64. PubMed ID: 12065635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
    Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
    J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol sensitivity of heteromeric NMDA receptors: effects of subunit assembly, glycine and NMDAR1 Mg(2+)-insensitive mutants.
    Mirshahi T; Woodward JJ
    Neuropharmacology; 1995 Mar; 34(3):347-55. PubMed ID: 7630488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of glycine antagonist sites of N-methyl-D-aspartate receptor subtypes. Preferential interaction of CGP 61594 with NR1/2B receptors.
    Honer M; Benke D; Laube B; Kuhse J; Heckendorn R; Allgeier H; Angst C; Monyer H; Seeburg PH; Betz H; Mohler H
    J Biol Chem; 1998 May; 273(18):11158-63. PubMed ID: 9556603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal domains of both NR1 and NR2 subunits determine allosteric Zn2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors.
    Madry C; Mesic I; Betz H; Laube B
    Mol Pharmacol; 2007 Dec; 72(6):1535-44. PubMed ID: 17878266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of NR1 splicing on NR1/NR3B-type excitatory glycine receptors.
    Cavara NA; Orth A; Hollmann M
    BMC Neurosci; 2009 Apr; 10():32. PubMed ID: 19348678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits.
    Chandra T; Maier W; König HG; Hirzel K; Kögel D; Schüler T; Chandra A; Demirhan I; Laube B
    Neuroscience; 2005; 134(1):145-53. PubMed ID: 15964699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutation in the glycine binding pocket of the N-methyl-D-aspartate receptor NR1 subunit alters agonist efficacy.
    Wood MW; VanDongen HM; VanDongen AM
    Brain Res Mol Brain Res; 1999 Nov; 73(1-2):189-92. PubMed ID: 10581413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NR3A modulates the outer vestibule of the "NMDA" receptor channel.
    Wada A; Takahashi H; Lipton SA; Chen HS
    J Neurosci; 2006 Dec; 26(51):13156-66. PubMed ID: 17182766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenesis rescues spermine and Zn2+ potentiation of recombinant NMDA receptors.
    Zheng X; Zhang L; Durand GM; Bennett MV; Zukin RS
    Neuron; 1994 Apr; 12(4):811-8. PubMed ID: 8161453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rules of engagement for NMDA receptor subunits.
    Ulbrich MH; Isacoff EY
    Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14163-8. PubMed ID: 18779583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three pairs of cysteine residues mediate both redox and zn2+ modulation of the nmda receptor.
    Choi Y; Chen HV; Lipton SA
    J Neurosci; 2001 Jan; 21(2):392-400. PubMed ID: 11160420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.